Acute Bacterial Skin and Skin Structure Infections Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Acute Bacterial Skin and Skin Structure Infections Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.
DelveInsight’s “Acute Bacterial Skin and Skin Structure Infections Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of the Acute Bacterial Skin and Skin Structure Infections, historical and forecasted epidemiology as well as the Acute Bacterial Skin and Skin Structure Infections market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Unlock detailed insights into the Acute Bacterial Skin and Skin Structure Infections Market by downloading the comprehensive report from DelveInsight @ Acute Bacterial Skin and Skin Structure Infections Treatment Market Size
Key Takeaways from the Acute Bacterial Skin and Skin Structure Infections Market Report
- In July 2024:- Melinta Therapeutics, LLC- A Multicenter, Open-Label, Evaluator-Blinded, Randomized Study to Evaluate the Safety and Tolerability of Single-Dose IV Oritavancin vs SoC for the Treatment of Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections. This protocol describes a randomized, open-label study to evaluate the safety and tolerability of single-dose intravenous (IV) oritavancin diphosphate (oritavancin) versus standard of care (SoC) antibiotics for the treatment of pediatric subjects with acute bacterial skin and skin structure infections (ABSSSIs).
- According to a study in 2013, investigated the relationship among diabetes, ABSSSIs, and complications of ABSSSIs; stratified records of patients with and without diabetes, who were between the ages of birth and 64 years and had at least 1 episode of ABSSSI. The overall sample was comprised of 2,227,402 distinct episodes of ABSSSI, of which 10% occurred in patients with diabetes and the most commonly observed complication was osteomyelitis.
- Based on research in 2022, In Europe, total hospital incidence of ABSSSIs was 1.8 per 1000 patient-days, and total prevalence was 12.1 cases per 1000 hospital admissions (1.21%); The incidence and prevalence of skin infections and ABSSSIs varied between countries, with the highest incidence observed in Spain. Overall, 73.6% of 50,469 admissions with a diagnosis of skin infection were due to ABSSSIs
- In a study in 2009, ABSSSI accounted for almost 870,000 hospital admissions in the United States in 2004 which represents an increase of almost 30% in the incidence of this diagnosis over a 4-year period.
- The leading Acute Bacterial Skin and Skin Structure Infections Companies such as Melinta Therapeutics, LLC, Merck, Pfizer, Allergan, Paratek Pharmaceuticals, Cumberland Pharmaceuticals, Teva Pharmaceuticals, and others.
- Promising Acute Bacterial Skin and Skin Structure Infections Therapies such as Contezolid acefosamil, Rifaquizinone (TNP-2092), and others.
Gain a competitive edge in the Acute Bacterial Skin and Skin Structure Infections Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Acute Bacterial Skin and Skin Structure Infections Treatment Drugs
Acute Bacterial Skin and Skin Structure Infections Epidemiology Segmentation in the 7MM
- Total Incident Cases of ABSSSI community/hospital
- Acute Bacterial Skin and Skin Structure Infections Age-specific Incident Cases
- Acute Bacterial Skin and Skin Structure Infections Gender-specific Incident Cases
- Acute Bacterial Skin and Skin Structure Infections Pathogen-specific Incident Cases
Acute Bacterial Skin and Skin Structure Infections Market Insights
Management of an ABSSSI is based on a multidisciplinary approach. The first step of management of an ABSSSI is the evaluation of hemodynamic state. Eradication of the causative organism, alleviation of signs and symptoms and avoidance of complications and preventing recurrences are the main goals of ABSSSI therapy. Treatment for ABSSSI usually includes an antimicrobial therapy, surgical drainage, and antibiotic therapy. The therapeutic approaches favored in treating skin infections include adjunctive therapies, early and appropriate empiric antibiotic therapy, wound culture with susceptibility testing and surgical drainage and debridement. Adjunctive therapies comprise daily dressing changes, use of topical solutions including non-specific antimicrobial drugs, hyperbaric oxygen treatments, debridement, and surgical interventions planned at the initiation of treatment.
Discover key developments and opportunities in the Acute Bacterial Skin and Skin Structure Infections Market. Click here to learn more from DelveInsight’s latest report @ Acute Bacterial Skin and Skin Structure Infections Market Size
Acute Bacterial Skin and Skin Structure Infections Treatment Market
Treatment of ABSSSI is quite challenging, as there is an increased antimicrobial resistance among both Gram-positive and Gram-negative bacteria with methicillin-resistant, however the mainstays of treatment continue to be antimicrobial therapies combined with appropriate surgical intervention however, in an overall perspective, recent, and extensive research and development activities being conducted for development of novel drugs, increase understanding of the related comorbidities, along with the number of upcoming pipeline drugs, is expected to create a lucrative environment for growth of ABSSSI treatment market.
Acute Bacterial Skin and Skin Structure Infections Drugs Market Landscape
The Acute Bacterial Skin and Skin Structure Infections drugs market for treatments targeting Acute Bacterial Skin and Skin Structure Infections (ABSSSI) is xperiencing notable growth, driven by the increasing incidence of these infections and the rising prevalence of antibiotic-resistant bacteria. Innovations in antibiotic therapies, including novel agents and combination therapies, are expanding treatment options and fueling market expansion. Additionally, the growing focus on personalized medicine and rapid diagnostic tools is enhancing the management of ABSSSI. Increased investment in research and development by pharmaceutical companies and the expanding market for advanced healthcare solutions contribute to the sector’s robust growth. As healthcare systems grapple with the challenges of resistant infections, the demand for effective ABSSSI treatments is expected to continue rising.
Download DelveInsight’s Acute Bacterial Skin and Skin Structure Infections Market report today and stay ahead in this rapidly evolving field. @ Acute Bacterial Skin and Skin Structure Infections Clinical Trials
Scope of the Acute Bacterial Skin and Skin Structure Infections Market Report
- Coverage- 7MM
- Acute Bacterial Skin and Skin Structure Infections Companies- Melinta Therapeutics, LLC, Merck, Pfizer, Allergan, Paratek Pharmaceuticals, Cumberland Pharmaceuticals, Teva Pharmaceuticals, and others.
- Acute Bacterial Skin and Skin Structure Infections Therapies- Contezolid acefosamil, Rifaquizinone (TNP-2092), and others.
- Acute Bacterial Skin and Skin Structure Infections Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
- Acute Bacterial Skin and Skin Structure Infections Unmet Needs, KOL’s views, Analyst’s views, Acute Bacterial Skin and Skin Structure Infections Market Access and Reimbursement
Download the report to understand which factors are driving Acute Bacterial Skin and Skin Structure Infections Market Trends @ Acute Bacterial Skin and Skin Structure Infections Market Trends
Table of Content
1. Key Insights
2. Report Introduction
3. Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) Market Overview at a Glance
4. Epidemiology and Market Methodology
5. Executive Summary of ABSSSI
6. Key Event
7. Disease Background and Overview
8. Epidemiology and Patient Population
9. Patient Journey
10. Marketed Therapies
11. Emerging Therapies
12. ABSSSI: Seven Major Market Analysis
13. Key Opinion Leaders’ Views
14. SWOT Analysis
15. Unmet Needs
16. Market Access and Reimbursement
17. Appendix
18. Bibliography
19. Acronyms and Abbreviations
20. Disclaimer
21. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/